News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Seattle's Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta AB (SE:EKTAB) VMAT



7/30/2008 11:15:54 AM

SEATTLE & ATLANTA--(BUSINESS WIRE)--Regulatory News: A patient with pancreatic cancer recently became the first person in the United States to receive treatment using Elekta VMAT (Volumetric intensity Modulated Arc Therapy) at Seattle’s Swedish Cancer Institute. This revolutionary new technology dramatically decreases treatment times – delivering a higher dose to the tumor target without compromising coverage and patient safety.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES